Clinical Trials
9 trialsNCT02620280 2024-03-06
NeoTRIPaPDL1
Fondazione Michelangelo
Phase 3 Completed
NCT00026286 2023-06-15
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT00433589 2022-11-17
MINDACT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT01583426 2020-08-06
GeparSepto
GBG Forschungs GmbH
Phase 3 Completed
NCT00004205 2017-12-12
BIG 1-98
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT02125344 2017-07-13
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
GBG Forschungs GmbH
Phase 3 Completed
NCT00044291 2015-07-31
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Completed
NCT00002967 2013-06-21
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01508546 2012-01-12
Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3 Completed